Skip to main content
. 2020 Sep 17;11(9):766. doi: 10.1038/s41419-020-02938-4

Fig. 1. Anlotinib inhibits the proliferation of pancreatic cancer cell lines in vitro.

Fig. 1

ac Dose- and time-dependent curves showing the percentage of inhibition of PC cells. BxPC-3, PANC-1 and SW1990 cells were treated with various concentrations of anlotinib (0–40 μM) for 24, 48 or 72 h. A CCK-8 assay was used to determine the viability of PC cells. de Colony formation was analysed. Each PC cell line was treated with 0, 5, 10 and 20 μM anlotinib for 24 h and cultured for 7 days. fi An image (the length of the bar is 100 μm) of EdU staining of PC cells after anlotinib treatment for 24 h. The data are presented as the mean ± SD from three independent experiments (*p < 0.05; **p < 0.01; ***p < 0.001).